Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Helus Pharma notches successful Phase 3 depression readout

Helus Pharma, part of the budding class of psychedelics companies, said its lead drug improved depression symptoms compared to placebo, but investors appeared slightly skittish about the safety profile. The company said

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at endpoints.news →

More in Health & Medicine

More from Monday 16 November →